Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.


Journal

Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370

Informations de publication

Date de publication:
02 2020
Historique:
received: 12 06 2019
accepted: 01 10 2019
pubmed: 17 12 2019
medline: 30 1 2021
entrez: 17 12 2019
Statut: ppublish

Résumé

Evaluate the efficacy of folic acid (FA) as a therapeutic adjunct to lithium (Li) on the manic-like behaviors as well as parameters of oxidative stress and inflammation in an animal model of mania induced by m-amphetamine (m-AMPH). Wistar rats first received m-AMPH or saline (NaCl 0.9%, Sal) for 14 days. Between the 8th and 14th day, rats were treated with water, Li, FA or a combination of thereof drugs (Li + FA). Manic-like behaviors were assessed in the open-field test. Oxidative stress and inflammation parameters were assessed in the frontal cortex, striatum, and hippocampus. Administration of m-AMPH in rats significantly enhanced the exploratory and locomotor behaviors, as well as the risk-taking and stereotypic behaviors. Li + FA reversed these behavioral alterations elicited by m-AMPH. Administration of this psychostimulant also increased oxidative damage to lipids and proteins, whereas Li + FA reversed these oxidative damages. m-AMPH also induced an increase in the glutathione peroxidase (GPx) activity and a decrease in the glutathione reductase (GR) activity. Li + FA reversed the alteration in GR activity, but not in GPx activity. In addition, m-AMPH increased the IL-1β and TNF-α levels in the rat brain; Li + FA combined therapy reversed the alterations on these inflammatory parameters. FA administration per se reduced the increased TNF-α content induced by m-AMPH. Present study provides evidence that FA is effective as an adjunct to Li standard therapy on manic-like behaviors, oxidative stress and inflammatory parameters in a model of mania induced by m-AMPH.

Identifiants

pubmed: 31840201
doi: 10.1007/s11011-019-00503-3
pii: 10.1007/s11011-019-00503-3
doi:

Substances chimiques

Antimanic Agents 0
Central Nervous System Stimulants 0
Inflammation Mediators 0
Folic Acid 935E97BOY8
Lithium 9FN79X2M3F
Amphetamine CK833KGX7E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-425

Références

Health Technol Assess. 2014 Jul;18(48):vii-viii, 1-159
pubmed: 25052890
Bipolar Disord. 2001 Apr;3(2):68-72
pubmed: 11333065
Pharm Biol. 2017 Dec;55(1):1295-1303
pubmed: 28274156
J Affect Disord. 1986 Jan-Feb;10(1):9-13
pubmed: 2939126
J Psychiatr Res. 1989;23(2):157-62
pubmed: 2511299
Int J Neuropsychopharmacol. 2018 Jun 1;21(6):550-569
pubmed: 29596661
Depress Anxiety. 2014 May;31(5):379-90
pubmed: 24353094
J Clin Psychopharmacol. 2017 Feb;37(1):40-45
pubmed: 27902528
Neurosci Biobehav Rev. 2011 Jan;35(3):804-17
pubmed: 20934453
Proc Nutr Soc. 2017 Nov;76(4):427-436
pubmed: 28942748
Expert Opin Ther Targets. 2015 Jul;19(7):927-39
pubmed: 25882812
Pharmacol Biochem Behav. 2012 Mar;101(1):148-54
pubmed: 22227220
Clin Pharmacokinet. 2017 Jan;56(1):77-90
pubmed: 27393139
Neurosci Lett. 2012 Nov 14;530(1):75-9
pubmed: 23022501
Bipolar Disord. 2010 Jun;12(4):414-24
pubmed: 20636639
Aust N Z J Psychiatry. 2013 Nov;47(11):1013-8
pubmed: 23969624
Mol Psychiatry. 2015 Jun;20(6):661-70
pubmed: 25687772
Pediatr Neurol. 2007 Dec;37(6):387-97
pubmed: 18021918
Br J Psychiatry. 1982 Jul;141:87-9
pubmed: 7116078
Lancet Psychiatry. 2016 Jan;3(1):31-39
pubmed: 26687300
Xenobiotica. 2014 May;44(5):480-8
pubmed: 24494987
Bipolar Disord. 2018 Dec;20(8):733-745
pubmed: 30375699
Curr Psychiatry Rep. 2015 Feb;17(2):8
pubmed: 25620790
Pharmacol Biochem Behav. 2019 Aug;183:56-63
pubmed: 31158395
J Psychiatr Res. 2014 Mar;50:36-41
pubmed: 24332923
Lancet. 2016 Apr 9;387(10027):1561-1572
pubmed: 26388529
Acta Psychiatr Scand. 2009 Dec;120(6):441-5
pubmed: 19392814
Int J Bipolar Disord. 2017 Oct 13;5(1):35
pubmed: 29027157
Arch Gen Psychiatry. 2011 Mar;68(3):241-51
pubmed: 21383262
Neurosci Biobehav Rev. 2014 Nov;47:307-20
pubmed: 25173634
Bipolar Disord. 2017 Sep;19(6):477-486
pubmed: 28833962
Cardiovasc Toxicol. 2011 Mar;11(1):67-73
pubmed: 21076891
Cell Mol Neurobiol. 2011 Jan;31(1):83-91
pubmed: 21170581
Behav Brain Res. 2014 Apr 1;262:94-100
pubmed: 24445072
Braz J Psychiatry. 2013;35 Suppl 2:S121-31
pubmed: 24271224
J Neural Transm (Vienna). 2012 Jan;119(1):31-8
pubmed: 21858431
Mol Neurobiol. 2019 Jan;56(1):141-156
pubmed: 29681025
J Neurochem. 2019 Mar;148(6):779-795
pubmed: 30556914
Psychother Psychosom. 2013;82(1):10-9
pubmed: 23147067
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:22-34
pubmed: 26545487
Bipolar Disord. 2006 Jun;8(3):275-80
pubmed: 16696830
Brain Res. 2005 Nov 9;1061(2):114-7
pubmed: 16256963
Int J Dev Neurosci. 2007 Dec;25(8):545-52
pubmed: 18023318
Int J Bipolar Disord. 2014 Dec 20;2:15
pubmed: 25530932
Eur Psychiatry. 2017 Jun;43:81-91
pubmed: 28371745
J Affect Disord. 1997 Nov;46(2):95-9
pubmed: 9479613
Trends Neurosci. 2003 Mar;26(3):137-46
pubmed: 12591216
Bipolar Disord. 2015 Aug;17(5):507-17
pubmed: 25929806
Altern Med Rev. 2008 Sep;13(3):216-26
pubmed: 18950248
J Affect Disord. 2017 Jan 01;207:429-433
pubmed: 27794238
Australas Psychiatry. 2017 Aug;25(4):369-372
pubmed: 28135835
Mol Chem Neuropathol. 1997 May;31(1):65-72
pubmed: 9271006
J Psychopharmacol. 2005 Jan;19(1):59-65
pubmed: 15671130
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
Transl Psychiatry. 2019 Jun 4;9(1):158
pubmed: 31164628
Mol Genet Metab. 2000 Sep-Oct;71(1-2):121-38
pubmed: 11001804
Bioinform Biol Insights. 2018 Dec 11;12:1177932218815152
pubmed: 30559594
Pharmacol Biochem Behav. 2013 Jan;103(3):589-96
pubmed: 23010382

Auteurs

Samira Menegas (S)

Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil.

Gustavo C Dal-Pont (GC)

Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil.

José H Cararo (JH)

Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil.

Roger B Varela (RB)

Queensland Brain Institute, The Universty of Queensland, St Lucia, QLD, 4072, Australia.

Jorge M Aguiar-Geraldo (JM)

Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil.

Taise Possamai-Della (T)

Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil.

Monica L Andersen (ML)

Department of Psychobiology, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil.

João Quevedo (J)

Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil.
Translational Psychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Neuroscience Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

Samira S Valvassori (SS)

Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil. samiravalvassori@unesc.net.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH